We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04274907
Brief Title: A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

First Submitted : February 17, 2020
First Submitted that Met QC Criteria : February 17, 2020
First Posted : February 18, 2020

Last Update Submitted that Met QC Criteria : February 10, 2021
Last Update Posted : February 11, 2021